ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

ClinicalTrials.gov ID: NCT06321302

Public ClinicalTrials.gov record NCT06321302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CRIMSON: A Multicentre, Randomised, Sham-controlled (and Active Controlled in the USA), Double-masked, 72-week Trial to Study the Safety, Tolerability, Pharmacokinetics, and Efficacy of 3 Dosing Regimens of Intravitreal BI 764524 in Patients With Moderate to Severe Non-proliferative Diabetic Retinopathy

Study identification

NCT ID
NCT06321302
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
187 participants

Conditions and interventions

Interventions

  • Aflibercept (Eylea®) - US only Drug
  • BI 764524 Drug
  • Sham comparator to BI 764524 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2024
Primary completion
Mar 4, 2027
Completion
Aug 19, 2027
Last update posted
Apr 27, 2026

2024 – 2027

United States locations

U.S. sites
40
U.S. states
17
U.S. cities
36
Facility City State ZIP Site status
Associated Retina Consultants, Ltd. Phoenix Arizona 85020
California Retina Consultants-Bakersfield-65523 Bakersfield California 93309
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
Retinal Diagnostic Center Campbell California 95008
The Retina Partners Encino California 91436
Lugene Eye Institute Glendale California 91204
Retina Associates of Southern California Huntington Beach California 92647
Byers Eye Institute Palo Alto California 94303
California Eye Specialists Medical Group Inc Pasadena California 91107
Retinal Consultants Medical Group Sacramento California 95825
Retinal Consultants Medical Group Sacramento California 95841
California Retina Consultants-Santa Maria-65510 Santa Maria California 93454
Bay Area Retina Associates - Walnut Creek Walnut Creek California 94598
Colorado Retina Associates Lakewood Colorado 80228
Retina Group of New England, PC Waterford Connecticut 06385
Florida Retina Institute Jacksonville Florida 32216
Florida Retina Consultants Lakeland Florida 33805
East Florida Eye Institute Stuart Florida 34994
Center for Retina and Macular Disease Winter Haven Florida 33880
Retina Consultants Of Hawaii ‘Aiea Hawaii 96701
Maine Eye Center Portland Maine 04101
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
Deep Blue Retina Clinical Research PLLC Southaven Mississippi 38671
NJRetina Teaneck New Jersey 07666
Long Island Vitreoretinal Consultants Great Neck New York 11021
Retina Vitreous Surgeons of Central NY, PC Liverpool New York 13088
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
EyeHealth Northwest Portland Oregon 97225
Charleston Neuroscience Institute - Ladson Ladson South Carolina 29456
Tennessee Retina Nashville Tennessee 37203
Austin Retina Associates Austin Texas 78705
Retina Research Center, PLLC Austin Texas 78705
Austin Clinical Research, LLC Austin Texas 78750
Retina Consultants of Texas Katy Texas 77494
Valley Retina Institute, PA McAllen Texas 78503
Austin Retina Associates Round Rock Texas 78681
Medical Center Ophthalmology Associates San Antonio Texas 78240
Retina Consultants of Texas San Antonio Texas 78240
Retina Consultants of Texas - Schertz Schertz Texas 78154
Retina Associates of Utah Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06321302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06321302 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →